On September 9, 2019 CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reported that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company at the 21st Annual Global Investment Conference sponsored by H.C. Wainwright & Co. on Tuesday, September 10, 2019 in New York, NY (Press release, Cytosorbents, SEP 9, 2019, https://www.prnewswire.com/news-releases/cytosorbents-to-present-at-the-hc-wainwright-21st-annual-global-investment-conference-300913899.html [SID1234539391]). Both Dr. Chan and Chief Financial Officer, Kathleen Bloch will meet with investors in 1×1 meetings during the conference on September 9-10, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

21st Annual Global Investment Conference sponsored by H.C. Wainwright & Co.
Where: Lotte New York Palace, 455 Madison Ave, New York, NY
When: Tuesday, September 10, 2019 from 4:40-5:05PM EDT
Room: Holmes II
Webcast: 21st Annual Global Investment Conference Webcast Link

A live webcast of the presentation will be available at the above webcast link. An archived replay of the webcast will be available for 90 days following the event.